The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma
Vo, Josh N., Wu, Yi-Mi, Mishler, Jeanmarie, Hall, Sarah, Mannan, Rahul, Wang, Lisha, Ning, Yu, Zhou, Jin, Hopkins, Alexander C., Estill, James C., Chan, Wallace K. B., Yesil, Jennifer, Cao, Xuhong, Rao, Arvind, Tsodikov, Alexander, Talpaz, Moshe, Cole, Craig E., Ye, Jing C., Bergsagel, P. Leif, Auclair, Daniel, Cho, Hearn Jay, Robinson, Dan R., Chinnaiyan, Arul M.
Published in Nature communications (29.06.2022)
Published in Nature communications (29.06.2022)
Get full text
Journal Article
Safety and Tolerability of Fedratinib (FEDR), an Oral Inhibitor of Janus Kinase 2 (JAK2), in Patients with Intermediate- or High-Risk Myelofibrosis (MF) Previously Treated with Ruxolitinib (RUX): Results from the Phase 3b FREEDOM Trial
Gupta, Vikas, Yacoub, Abdulraheem, Verstovsek, Srdan, Mesa, Ruben A., Harrison, Claire N., Barosi, Giovanni, Kiladjian, Jean-Jacques, Deeg, H. Joachim, Fazal, Salman, Foltz, Lynda, Mattison, Ryan J., Miller, Carole B., Parameswaran, Vinod, Gharpure, Vishwanath, Hernandez, Christopher, Wang, Tianhua, Talpaz, Moshe
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Spleen and Symptom Responses with Fedratinib (FEDR) in Patients with Myelofibrosis (MF) and Substantial Splenomegaly
Kiladjian, Jean-Jacques, Tefferi, Ayalew, Passamonti, Francesco, Vannucchi, Alessandro, Talpaz, Moshe, Cervantes, Francisco, Harrison, Claire N., Mesa, Ruben A., Mascarenhas, John, Schaap, Nicolaas, Verstovsek, Srdan, Devos, Timothy, Rose, Shelonitda, Zhang, Jun, Sy, Oumar, Pardanani, Animesh
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia
Ouillette, Peter, Collins, Roxane, Shakhan, Sajid, Li, Jinghui, Peres, Edward, Kujawski, Lisa, Talpaz, Moshe, Kaminski, Mark, Li, Cheng, Shedden, Kerby, Malek, Sami N.
Published in Blood (15.09.2011)
Published in Blood (15.09.2011)
Get full text
Journal Article
Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies
He, Tongchen, Xiao, Lanbo, Qiao, Yuanyuan, Klingbeil, Olaf, Young, Eleanor, Wu, Xiaoli S., Mannan, Rahul, Mahapatra, Somnath, Redin, Esther, Cho, Hanbyul, Bao, Yi, Kandarpa, Malathi, Ching-Yi Tien, Jean, Wang, Xiaoju, Eyunni, Sanjana, Zheng, Yang, Kim, NamHoon, Zheng, Heng, Hou, Siyu, Su, Fengyun, Miner, Stephanie J., Mehra, Rohit, Cao, Xuhong, Abbineni, Chandrasekhar, Samajdar, Susanta, Ramachandra, Murali, Dhanasekaran, Saravana M., Talpaz, Moshe, Parolia, Abhijit, Rudin, Charles M., Vakoc, Christopher R., Chinnaiyan, Arul M.
Published in Cancer cell (12.08.2024)
Published in Cancer cell (12.08.2024)
Get full text
Journal Article
Tumor/normal genomic profiling in patients with metastatic solid tumors identifies pathogenic germline variants of therapeutic importance
Cobain, Erin Frances, Jacobs, Michelle, Wu, Yi-Mi, Robinson, Dan R., Vats, Pankaj, Chugh, Rashmi, Talpaz, Moshe, Stoffel, Elena Martinez, Chinnaiyan, Arul
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia
Schilling, Paul J., Kurzrock, Razelle, Kantarjian, Hagop, Gutterman, Jordan U., Talpaz, Moshe
Published in Cancer (01.10.1991)
Published in Cancer (01.10.1991)
Get full text
Journal Article
ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial
Oh, Stephen T., Talpaz, Moshe, Gerds, Aaron T., Gupta, Vikas, Verstovsek, Srdan, Mesa, Ruben, Miller, Carole B., Rivera, Candido E., Fleischman, Angela G., Goel, Swati, Heaney, Mark L., O'Connell, Casey, Arcasoy, Murat O., Zhang, Yafeng, Kawashima, Jun, Ganz, Tomas, Kowalski, Mark, Brachmann, Carrie Baker
Published in Blood advances (22.09.2020)
Published in Blood advances (22.09.2020)
Get full text
Journal Article
A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
Mascarenhas, John, Migliaccio, Anna Rita, Kosiorek, Heidi, Bhave, Rupali, Palmer, Jeanne, Kuykendall, Andrew, Mesa, Ruben, Rampal, Raajit K., Gerds, Aaron T., Yacoub, Abdulraheem, Pettit, Kristen, Talpaz, Moshe, Komrokji, Rami, Kremyanskaya, Marina, Gonzalez, Agapito, Fabris, Frank, Johnson, Kathryn, Dougherty, Mikaela, McGovern, Erin, Arango Ossa, Juan, Domenico, Dylan, Farnoud, Noushin, Weinberg, Rona Singer, Kong, Amy, Najfeld, Vesna, Vannucchi, Alessandro Maria, Arciprete, Francesca, Zingariello, Maria, Falchi, Mario, Salama, Mohamed E., Mead-Harvey, Carolyn, Dueck, Amylou, Varricchio, Lilian, Hoffman, Ronald
Published in Clinical cancer research (15.09.2023)
Published in Clinical cancer research (15.09.2023)
Get full text
Journal Article
MPN-133 Reduction in Red Blood Cell Transfusion Burden: A Novel Longitudinal Time-Dependent Analysis in Patients With Transfusion-Dependent Myelofibrosis Treated With Momelotinib
Harrison, Claire, Mesa, Ruben, Talpaz, Moshe, Gupta, Vikas, Gerds, Aaron, Klencke, Barbara, Ellis, Catherine, Kawashima, Jun, Donohue, Rafe, Strouse, Bryan, Oh, Stephen
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article
POSTER: MPN-133 Reduction in Red Blood Cell Transfusion Burden: A Novel Longitudinal Time-Dependent Analysis in Patients With Transfusion-Dependent Myelofibrosis Treated With Momelotinib
Harrison, Claire, Mesa, Ruben, Talpaz, Moshe, Gupta, Vikas, Gerds, Aaron, Klencke, Barbara, Ellis, Catherine, Kawashima, Jun, Donohue, Rafe, Strouse, Bryan, Oh, Stephen
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article
CML and the WHO: Why?
Berman, Ellin, Shah, Neil P, Deninger, Michael, Altman, Jessica K, Amaya, Maria, Begna, Kebede, Bhatia, Ravi, Chan, Onyee, Collins, Robert, Curtin, Peter, DeAngelo, Daniel J, Drazer, Michael, Maness, Lori, Metheny, Leland, Mohan, Sanjay, Moore, Joseph, Oehler, Vivian, Pratz, Keith, Pusic, Iskra, Rose, Michal, Shomali, William, Smith, B Douglas, Styler, Michael, Sweet, Kendra, Talpaz, Moshe, Tanaka, Tiffany, Tantravahi, Srinivas, Tsai, Steven, Vaughn, Jennifer, Welborn, Jeanna, Yang, David, Mauro, Michael, Cortes, Jorge, Radich, Jerald, Druker, Brian
Published in Journal of clinical oncology (20.03.2024)
Published in Journal of clinical oncology (20.03.2024)
Get full text
Journal Article
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results
Cortes, Jorge E., Sasaki, Koji, Kim, Dong-Wook, Hughes, Timothy P., Etienne, Gabriel, Mauro, Michael J., Hochhaus, Andreas, Lang, Fabian, Heinrich, Michael C., Breccia, Massimo, Deininger, Michael, Goh, Yeow Tee, Janssen, Jeroen J.W.M., Talpaz, Moshe, de Soria, Valle Gomez Garcia, le Coutre, Philipp, DeAngelo, Daniel J., Damon, Andrea, Cacciatore, Silvia, Polydoros, Fotis, Agrawal, Nithya, Rea, Delphine
Published in Leukemia (01.07.2024)
Published in Leukemia (01.07.2024)
Get full text
Journal Article
Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib
Gerds, Aaron T., Tauchi, Tetsuzo, Ritchie, Ellen, Deininger, Michael, Jamieson, Catriona, Mesa, Ruben, Heaney, Mark, Komatsu, Norio, Minami, Hironobu, Su, Yun, Shaik, Naveed, Zhang, Xiaoxi, DiRienzo, Christine, Zeremski, Mirjana, Chan, Geoffrey, Talpaz, Moshe
Published in Leukemia research (01.04.2019)
Published in Leukemia research (01.04.2019)
Get full text
Journal Article
BMS-986158, a Potent BET Inhibitor, in Combination with Ruxolitinib or Fedratinib in Patients (pts) with Intermediate- or High-Risk Myelofibrosis (MF): Updated Results from a Phase 1/2 Study
Lavie, David, Ribrag, Vincent, Loschi, Michael, Yannakou, Costas K., Alwan, Maan, Abulafia, Adi Schacham, Hernández-Rivas, Jesús María, Volchek, Yulia, Fong, Chun Yew, Bonifacio, Massimiliano, Kiladjian, Jean-Jacques, Ianotto, Jean-Christophe, García Gutiérrez, Valentín, Tucci, Alessandra, Xicoy, Blanca, Al-Ali, Haifa Kathrin, Talpaz, Moshe, Gerber, Jonathan M., Raman, Indu, Tomuleasa, Ciprian, Lee-Hoeflich, Si Tuen, Das, Sharmila, Wu, Bin, Zhao, Qian, Kim, Eunhee, Esposito, Oriana, Liu, Yu, Nikolova, Zariana, Tehlirian, Christopher, Coker, Shodeinde, Ayala, Rosa
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase
Guilhot, Francois, Apperley, Jane, Kim, Dong-Wook, Bullorsky, Eduardo O., Baccarani, Michele, Roboz, Gail J., Amadori, Sergio, de Souza, Carmino A., Lipton, Jeffrey H., Hochhaus, Andreas, Heim, Dominik, Larson, Richard A., Branford, Susan, Muller, Martin C., Agarwal, Prasheen, Gollerkeri, Ashwin, Talpaz, Moshe
Published in Blood (15.05.2007)
Published in Blood (15.05.2007)
Get full text
Journal Article
The combination of venetoclax, lenalidomide, and rituximab in patients with newly diagnosed mantle cell lymphoma induces high response rates and MRD undetectability
Phillips, Tycel Jovelle, Danilov, Alexey Valeryevich, Bond, David Alan, Herrera, Alex Francisco, Maddocks, Kami J., Devata, Sumana, Karimi, Yasmin, Carty, Shannon, Wilcox, Ryan A., Kaminski, Mark Stefan, Malek, Sami N., Talpaz, Moshe, Popplewell, Leslie
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Fedratinib Induces Cytokine Changes Correlating with Clinical Response in Ruxolitinib Exposed Myelofibrosis Patients: Biomarker Analysis from the Freedom Trial
Jeyaraju, Danny V, Hayati, Sheida, Polonskaia, Ann, Alapa, Maryam, Ugidos, Manuel, Browne, Andrew, Risueño, Alberto, Hagner, Patrick, Gupta, Vikas, Talpaz, Moshe, Hernandez, Christopher, Chia, Vincent, Martin-Regueira, Patricia, Lopes de Menezes, Daniel, La Motte-Mohs, Ross, Suragani, Rajasekhar NVS, Gandhi, Anita K.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article